SomnoMed Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.25 |
Market Cap |
AUD96.72 M |
Shares Outstanding |
62.8 M |
Public Float |
42.14 M |
SomnoMed Ltd. | |
Stock Exchange | Boerse Berlin |
EPS |
- |
Market Cap |
EUR138.78 M |
Shares Outstanding |
62.21 M |
Public Float |
- |
SomnoMed Ltd. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
62.21 M |
Public Float |
- |
Address |
20 Clarke Street Sydney New South Wales (NSW) 2065 Australia |
Employees | - |
Website | http://www.somnomed.com.au |
Updated | 07/08/2019 |
SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep disordered breathing relieving conditions. The company was founded on March 16, 1987 and is headquartered in Sydney, Australia. |